Cholesterol lowering medication - patients' knowledge, attitudes and experiences (original) (raw)
Evaluation of Perceptions, Knowledge and Compliance with tHE Guidelines in Real Life Practice: A survey on the Under-treatment of HypercholeSterolemia
Mujdat Aktas
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2019
View PDFchevron_right
The role of guidelines and the patient's life-style in GPs' management of hypercholesterolaemia
Johan Bring
BMC family practice, 2004
View PDFchevron_right
Rationale, design, and methodology of the Evaluation of Perceptions, Knowledge, and Compliance with the Guidelines in Real Life Practice: A Survey on the Under-treatment of Hypercholesterolemia
Bülent Özlek
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2018
View PDFchevron_right
Prevalence, factors influencing and knowledge about adherence to lipid-lowering therapy among hyperlipidemia patients
Norita binti Hussein
PubMed, 2017
View PDFchevron_right
Attitudes and behavior of peripheral arterial disease patients toward influencing their physician's prescription of cholesterol-lowering medication
Barbara Olendzki
Vascular Medicine, 2010
View PDFchevron_right
Patients’ Perspectives on Statin Therapy for Treatment of Hypercholesterolaemia: A Qualitative Study
Grace Lindsay
European Journal of Cardiovascular Nursing, 2003
View PDFchevron_right
Increasing physician involvement in cholesterol-lowering practices
Karen Mann
Journal of Continuing Education in the Health Professions, 1996
View PDFchevron_right
Cross-analysis of dietary prescriptions and adherence in 356 hypercholesterolaemic patients
Denis Pouchain
Archives of Cardiovascular Diseases, 2012
View PDFchevron_right
Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions
Victoria Senior
Cardiovascular drugs and therapy, 2004
View PDFchevron_right
Factors Related to Adherence with Treatment of Dyslipidemic Patients on Continuous Use of Oral Lipid-Lowering Drugs
Ana Marsola, Evandro Cesarino
Health, 2014
View PDFchevron_right
Family Physician's Knowledge, Beliefs, and Self-reported Practice Patterns Regarding Hyperlipidemia: A National Research Network (NRN) Survey
Aaron Bonham
The Journal of the …, 2006
View PDFchevron_right
Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the second study of cardiovascular risk intervention by pharmacists (SCRIP plus
Terri Schindel
American Journal of Medicine, 2004
View PDFchevron_right
Physician and patient barriers to adherence with cholesterol guidelines
asim khattak
The West Virginia medical journal
View PDFchevron_right
A community pharmacist delivered adherence support service for dyslipidaemia
Timothy Chen
The European Journal of Public Health, 2011
View PDFchevron_right
Clinical and Humanistic Outcomes of a Lipid Management Program in the Community Pharmacy Setting
Kamala Nola
Journal of the American Pharmaceutical Association, 2000
View PDFchevron_right
How to help patients manage their dyslipidemia: A primary care physician–pharmacist team intervention
Sylvie Perreault, Eveline Hudon
Canadian Pharmacists Journal, 2007
View PDFchevron_right
The importance of cholesterol medication adherence: the need for behavioral change intervention programs
Caroline ATLANI
Patient Preference and Adherence, 2018
View PDFchevron_right
A Systematic Review of the Evidence for Pharmacist Care of Patients With Dyslipidemia
Theresa Charrois
… : The Journal of …, 2012
View PDFchevron_right
General practitioners’ adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark
Torsten Lauritzen
Scandinavian Journal of Primary Health Care, 2010
View PDFchevron_right
Factors influencing GPs' decisions on the treatment of hypercholesterolaemic patients
Johan Bring
Scandinavian Journal of Primary Health Care, 2000
View PDFchevron_right
Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial
Mariano Blasco Valle
BMC cardiovascular disorders, 2015
View PDFchevron_right
Self-Reported Adherence to Nonpharmacological Treatment and Association with Mortality over 6 Years: Population-Based Study in Older Persons with Hypercholesterolemia
Luz León
Journal of the American Geriatrics Society, 2000
View PDFchevron_right
Use of cholesterol-lowering medications in the United States from 1991 to 199711The views expressed in this paper do not necessarily represent the views of the Department of Veterans Affairs or of the United States Government
Julio Lopez
The American Journal of Medicine, 2000
View PDFchevron_right
Knowledge, Attitude And Practice Of Hypercholesterolemic Type 2 Diabetic Subjects On Dyslipidemia
Liaquat Ali
Ibrahim Medical College Journal, 2012
View PDFchevron_right
Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes
Lorenzo Villa
Latin American Journal of Pharmacy, 2009
View PDFchevron_right
Sensitivity of patient outcomes to pharmacists interventions. Part II Systematic Review and Meta Analysis in Hyperlipedemia Management
Jana Lazor (Bajcar)
View PDFchevron_right
Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel
Robert Hegele
Canadian Journal of Cardiology, 2014
View PDFchevron_right